Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haitang Yang

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Journal of Cancer Research and Clinical Oncology|March 5, 2016
Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations in ChinaJianlin Xu, Yanwei Zhang, Bo Jin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 12, 2016
Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung CancerJianlin Xu, Haitang Yang, Xiaolong Fu, et al.
Translational Lung Cancer Research|September 12, 2022
The improved success rate and reduced complications of a novel localization device <i>vs.</i> hookwire for thoracoscopic resection of small pulmonary nodules: a single-center, open-label, randomized clinical trialLiwen Fan, Wenyan Ma, Jie Ma, et al.
Cancers|April 3, 2021
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural MesotheliomaHaitang Yang, Sean R R Hall, Beibei Sun, et al.
Analytical Chemistry|April 14, 2026
Photoactivatable Cascade DNAzyme Nanomachines for Amplified Imaging of Tumor Response to STING-Activated ImmunotherapyJiajia Pan, Haojie Wu, Yunxuan Chou, et al.
Advanced Healthcare Materials|September 15, 2023
One-Pot Synthesis of Tumor-Microenvironment Responsive Degradable Nanoflower-Medicine for Multimodal Cancer Therapy with Reinvigorating Antitumor ImmunityJiamin Sun, Kai Jiang, Yifan Wang, et al.
Translational Lung Cancer Research|March 21, 2025
Sleeve lobectomy versus lobectomy after neoadjuvant chemo-immunotherapy for non-small cell lung cancer invading the lobar bronchial orifice: a multicenter retrospective cohort studyTianyue Ma, Jun Yi, Yong Ge, et al.
Oncogenesis|August 22, 2019
HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancerHaitang Yang, Shun-Qing Liang, Duo Xu, et al.
International Journal of Cancer|April 10, 2026
Effect of Interval Between Neoadjuvant Immunochemotherapy and Radical Resection of Non-Small Cell Lung Cancer: A Multicenter, Retrospective Cohort StudyJiayi Wang, Pingping Song, Yong Ge, et al.
JTO Clinical and Research Reports|May 8, 2024
BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural MesotheliomaDuo Xu, Yanyun Gao, Haitang Yang, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Journal of Cancer Research and Clinical Oncology|March 5, 2016
Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations in ChinaJianlin Xu, Yanwei Zhang, Bo Jin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 12, 2016
Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung CancerJianlin Xu, Haitang Yang, Xiaolong Fu, et al.
Translational Lung Cancer Research|September 12, 2022
The improved success rate and reduced complications of a novel localization device <i>vs.</i> hookwire for thoracoscopic resection of small pulmonary nodules: a single-center, open-label, randomized clinical trialLiwen Fan, Wenyan Ma, Jie Ma, et al.
Cancers|April 3, 2021
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural MesotheliomaHaitang Yang, Sean R R Hall, Beibei Sun, et al.
Analytical Chemistry|April 14, 2026
Photoactivatable Cascade DNAzyme Nanomachines for Amplified Imaging of Tumor Response to STING-Activated ImmunotherapyJiajia Pan, Haojie Wu, Yunxuan Chou, et al.
Advanced Healthcare Materials|September 15, 2023
One-Pot Synthesis of Tumor-Microenvironment Responsive Degradable Nanoflower-Medicine for Multimodal Cancer Therapy with Reinvigorating Antitumor ImmunityJiamin Sun, Kai Jiang, Yifan Wang, et al.
Translational Lung Cancer Research|March 21, 2025
Sleeve lobectomy versus lobectomy after neoadjuvant chemo-immunotherapy for non-small cell lung cancer invading the lobar bronchial orifice: a multicenter retrospective cohort studyTianyue Ma, Jun Yi, Yong Ge, et al.
Oncogenesis|August 22, 2019
HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancerHaitang Yang, Shun-Qing Liang, Duo Xu, et al.
International Journal of Cancer|April 10, 2026
Effect of Interval Between Neoadjuvant Immunochemotherapy and Radical Resection of Non-Small Cell Lung Cancer: A Multicenter, Retrospective Cohort StudyJiayi Wang, Pingping Song, Yong Ge, et al.
JTO Clinical and Research Reports|May 8, 2024
BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural MesotheliomaDuo Xu, Yanyun Gao, Haitang Yang, et al.
Pageof 12